.jpg?format=webp&width=780)
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare type of vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA). It is characterized by asthma, elevated levels of eosinophils (a type of white blood cell), and the involvement of multiple organs. The diagnosis and management of EGPA can be challenging and require a multidisciplinary approach. Existing guidelines for ANCA-associated vasculitis are used for managing EGPA, but specific guidelines for EGPA are needed. In this study, European experts have developed evidence-based guidelines for diagnosing and managing EGPA. The guidelines include recommendations on diagnosis, staging, treatment, outcomes, and follow-up. They are intended for healthcare professionals, pharmaceutical industries, and drug regulatory authorities to improve clinical practice and decision-making in EGPA. It is important to note that these guidelines do not restrict access to medications or dictate a specific order of medication use.
Like
Save
Share